Release Date: 19/06/12 16:01 Summary: Ceasing to be a substantial holder Price Sensitive: No Download Document 397.1KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%